J&J Resumes Production at Suspended Tylenol Plant

Oct 16, 2015

Philadelphia Biz Journal

Johnson & Johnson's McNeil Consumer Healthcare officially resumed commercial production of over-the-counter meds at its Fort Washington, Pennsylvania plant, which temporarily shut down five years ago following a series of high-profile product recalls.

Following a lengthy series of recalls involving millions of product packages, McNeil had suspended manufacturing at its Fort Washington location -- the drugmaker's primary Tylenol and OTC manufacturing site.

The resumption of manufacturing was delayed several years while McNeil complied with the terms of a consent decree it signed with the FDA in March 2011.

McNeil says it recently had a successful FDA inspection at the site, after spending over $100 million on plant improvements.

Read the Philadelphia Biz Journal article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments